Redmile Group as of June 30, 2021
Portfolio Holdings for Redmile Group
Redmile Group holds 86 positions in its portfolio as reported in the June 2021 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Fate Therapeutics (FATE) | 16.6 | $1.1B | 13M | 86.79 | |
Igm Biosciences (IGMS) | 4.2 | $285M | 3.4M | 83.20 | |
Beam Therapeutics (BEAM) | 3.9 | $264M | 2.1M | 128.71 | |
Argenx Se Sponsored Adr (ARGX) | 3.5 | $238M | 790k | 301.07 | |
Amicus Therapeutics (FOLD) | 3.0 | $201M | 21M | 9.64 | |
Allakos (ALLK) | 2.8 | $189M | 2.2M | 85.37 | |
Adc Therapeutics Sa SHS (ADCT) | 2.7 | $183M | 7.5M | 24.35 | |
Shattuck Labs (STTK) | 2.4 | $163M | 5.6M | 28.99 | |
Replimune Group (REPL) | 2.4 | $161M | 4.2M | 38.42 | |
Invitae (NVTAQ) | 2.3 | $157M | 4.6M | 33.73 | |
Deciphera Pharmaceuticals | 2.3 | $155M | 4.2M | 36.61 | |
Jazz Pharmaceuticals Shs Usd (JAZZ) | 2.3 | $153M | 860k | 177.64 | |
Medavail Holdings Ord | 2.1 | $144M | 12M | 12.25 | |
Krystal Biotech (KRYS) | 2.1 | $141M | 2.1M | 68.00 | |
Oak Street Health | 2.0 | $135M | 2.3M | 58.57 | |
Kymera Therapeutics (KYMR) | 1.8 | $123M | 2.5M | 48.50 | |
Seagen | 1.8 | $122M | 771k | 157.88 | |
Verve Therapeutics (VERV) | 1.7 | $117M | 1.9M | 60.25 | |
The Beauty Health Company Com Cl A (SKIN) | 1.6 | $107M | 6.4M | 16.80 | |
Celldex Therapeutics Com New (CLDX) | 1.5 | $101M | 3.0M | 33.44 | |
Atara Biotherapeutics | 1.5 | $100M | 6.4M | 15.55 | |
Nevro (NVRO) | 1.5 | $99M | 595k | 165.79 | |
Dex (DXCM) | 1.5 | $98M | 231k | 427.00 | |
Livanova SHS (LIVN) | 1.4 | $94M | 1.1M | 84.11 | |
Pliant Therapeutics (PLRX) | 1.4 | $92M | 3.2M | 29.12 | |
Nurix Therapeutics (NRIX) | 1.3 | $85M | 3.2M | 26.53 | |
Regenxbio Inc equity us cm (RGNX) | 1.2 | $83M | 2.1M | 38.85 | |
Stoke Therapeutics (STOK) | 1.2 | $83M | 2.5M | 33.66 | |
Repare Therapeutics Ord (RPTX) | 1.2 | $82M | 2.6M | 31.18 | |
Annexon (ANNX) | 1.1 | $77M | 3.4M | 22.51 | |
Epizyme | 1.0 | $71M | 8.5M | 8.31 | |
Akero Therapeutics (AKRO) | 1.0 | $70M | 2.8M | 24.81 | |
Scholar Rock Hldg Corp (SRRK) | 1.0 | $67M | 2.3M | 28.90 | |
Prothena Corp SHS (PRTA) | 0.9 | $63M | 1.2M | 51.41 | |
Zymergen | 0.9 | $61M | 1.5M | 40.01 | |
ImmunoGen | 0.9 | $59M | 8.9M | 6.59 | |
1life Healthcare | 0.8 | $55M | 1.7M | 33.06 | |
Ngm Biopharmaceuticals | 0.8 | $55M | 2.8M | 19.72 | |
Tcr2 Therapeutics Inc cs | 0.8 | $53M | 3.2M | 16.41 | |
Genmab A/s Sponsored Ads (GMAB) | 0.7 | $50M | 1.2M | 40.83 | |
Alx Oncology Hldgs (ALXO) | 0.7 | $50M | 914k | 54.68 | |
Selectquote Ord (SLQT) | 0.7 | $47M | 2.4M | 19.26 | |
ICU Medical, Incorporated (ICUI) | 0.7 | $46M | 223k | 205.80 | |
Nuvation Bio Com Cl A (NUVB) | 0.6 | $42M | 4.5M | 9.31 | |
Anthem (ELV) | 0.6 | $42M | 109k | 381.80 | |
Charles River Laboratories (CRL) | 0.6 | $40M | 108k | 369.92 | |
Cigna Corp (CI) | 0.6 | $38M | 160k | 237.07 | |
UnitedHealth (UNH) | 0.6 | $38M | 95k | 400.44 | |
Neoleukin Therapeutics | 0.5 | $36M | 3.9M | 9.23 | |
Lifestance Health Group (LFST) | 0.5 | $35M | 1.3M | 27.86 | |
Catalent | 0.5 | $34M | 310k | 108.12 | |
Zymeworks | 0.5 | $33M | 940k | 34.69 | |
Amedisys (AMED) | 0.5 | $32M | 133k | 244.93 | |
Allovir (ALVR) | 0.5 | $31M | 1.6M | 19.74 | |
Lava Therapeutics Nv SHS (LVTX) | 0.5 | $31M | 2.8M | 10.88 | |
Avita Therapeutics (RCEL) | 0.4 | $29M | 1.4M | 20.52 | |
Ardelyx (ARDX) | 0.4 | $28M | 3.7M | 7.58 | |
Bioventus Com Cl A (BVS) | 0.4 | $26M | 1.5M | 17.60 | |
Zentalis Pharmaceuticals (ZNTL) | 0.3 | $23M | 426k | 53.20 | |
Immatics SHS (IMTX) | 0.3 | $23M | 1.9M | 11.61 | |
Ppd | 0.3 | $22M | 467k | 46.09 | |
Atreca Cl A Com (BCEL) | 0.3 | $21M | 2.5M | 8.52 | |
Quantum Si Com Cl A (QSI) | 0.3 | $21M | 1.7M | 12.26 | |
Achilles Therapeutics Sponsored Ads (ACHL) | 0.3 | $20M | 2.1M | 9.79 | |
Gritstone Oncology Ord (GRTSQ) | 0.3 | $20M | 2.2M | 9.13 | |
Itamar Med Sponsored Ads | 0.3 | $20M | 855k | 23.55 | |
Dynamics Special Purpose Cor Class A Com | 0.3 | $20M | 2.0M | 9.94 | |
Innovage Hldg Corp (INNV) | 0.3 | $18M | 844k | 21.31 | |
Stereotaxis Com New (STXS) | 0.3 | $18M | 1.9M | 9.64 | |
Alpha Teknova (TKNO) | 0.3 | $17M | 725k | 23.73 | |
Hookipa Pharma Inc equity | 0.3 | $17M | 1.9M | 9.16 | |
Quanterix Ord (QTRX) | 0.2 | $14M | 241k | 58.66 | |
Profound Med Corp Com New (PROF) | 0.2 | $13M | 787k | 16.36 | |
Treace Med Concepts (TMCI) | 0.1 | $10M | 324k | 31.26 | |
Cytosorbents Corp Com New (CTSO) | 0.1 | $9.8M | 1.3M | 7.55 | |
Ayala Pharmaceuticals Incorporated | 0.1 | $6.8M | 668k | 10.19 | |
Neuronetics (STIM) | 0.1 | $6.3M | 394k | 16.02 | |
Cabaletta Bio (CABA) | 0.1 | $6.0M | 696k | 8.60 | |
Xeris Pharmaceuticals | 0.1 | $5.5M | 1.4M | 4.07 | |
Atea Pharmaceuticals (AVIR) | 0.1 | $5.1M | 237k | 21.48 | |
Talis Biomedical Corp | 0.1 | $4.0M | 364k | 11.03 | |
Aprea Therapeutics | 0.1 | $3.4M | 695k | 4.88 | |
Yumanity Therapeutics | 0.0 | $693k | 60k | 11.65 | |
Tricida | 0.0 | $237k | 55k | 4.33 | |
Syros Pharmaceuticals | 0.0 | $212k | 39k | 5.45 | |
Ovid Therapeutics (OVID) | 0.0 | $159k | 41k | 3.91 |